Boulder, Colorado, United States
With over 25 years of leadership experience transforming groundbreaking scientific discoveries and cutting-edge technologies into real-world solutions, I’ve built a career rooted in innovation, strategy, and execution. My career in start-ups has honed my ability to identify critical opportunities, navigate challenges, and drive success by focusing on what matters most. I have led the full lifecycle of life science products, from product development and manufacturing scale-up to clinical trials, product launches, and go-to-market strategies across diagnostics, medical devices, and therapeutics throughout the US, Europe and Asia. My expertise spans across building cross-functional teams, managing complex projects, and ensuring successful commercialization in highly regulated industries. I am a passionate problem solver with a talent for bringing diverse teams together to achieve common goals. With a proven track record in driving successful product commercialization and overcoming challenges, I’m committed to delivering impactful results in the life sciences industry to save lives and improve patient outcomes.
Orbit Genomics is transforming complex disease diagnosis, treatment and prevention through our patented, AI-enabled OrbiSeq™ platform that analyzes historically inaccessible genomic markers which uniquely reflect not only inherited predisposition to disease, but also risk acquired from lifestyle and environmental exposures. Our first product is a simple blood test to replace biopsies for diagnosing early-stage lung cancer.
Ventac Partners is a life science company builder with offices in the US, EU and Asia. Ventac Partners has a strong track record of successfully launching new companies, fundraising, deal making and strategic consulting.
Panion Animal Health AB ‘s aim is develop and commercialize the canine application of CombiGene AB’s technology for gene therapeutic treatment of drug refractory epilepsy. In addition, Panion plans to inlicense or acquire other, similar assets, i.e. the animal health applications of human health development projects or products. Panion was acquired by CombiGene in 2019.
Boulder Diagnostics Inc. is dedicated to bringing new diagnostic tests to market for diseases that are not reliably diagnosed today. We work with leading academic institutions and innovative companies to identify scientific breakthroughs that can deliver new, reliable diagnostic tests where today’s standard methods fail.